; (II) a description of the information submitted to the Secretary under clause (ii) (in a manner that does not disclose the identity of a pharmacy, a PDP sponsor, a prescription drug plan, or pharmacy benefit manager, or any proprietary pricing information); and (III) any other information determined appropriate by the Secretary. (v) Limited access drug defined In this subparagraph, the term limited access drug means a covered part D drug that meets at least one of the following: (I) The Food and Drug Administration has restricted distribution of such covered part D drug to certain facilities or physicians. (II) The dispensing of such covered part D drug requires extraordinary special handling, provider coordination, or patient education that cannot be met by a network pharmacy. .